vTv Therapeutics (VTVT) Minority Interest (2014 - 2025)

vTv Therapeutics (VTVT) has 12 years of Minority Interest data on file, last reported at -$357000.0 in Q2 2025.

• For the quarter ending Q2 2025, Minority Interest fell 109.01% year-over-year to -$357000.0; the trailing twelve-month figure through Jun 2025 stood at -$357000.0 (down 109.01% YoY), and the FY2024 full-year result was $2.1 million, down 65.72% from the prior year.
• Minority Interest fell to -$357000.0 in Q2 2025, from $977000.0 in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $62.6 million in Q1 2021 to a low of -$357000.0 in Q2 2025.
• A 5-year average of $20.3 million and a median of $16.2 million in 2022 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest surged 36.42% in 2023 and slumped 109.01% in 2025, its largest moves.
• Tracing VTVT's Minority Interest over 5 years: stood at $25.0 million in 2021, then plunged by 33.58% to $16.6 million in 2022, then sank by 63.02% to $6.1 million in 2023, then tumbled by 65.72% to $2.1 million in 2024, then plunged by 116.98% to -$357000.0 in 2025.
• Business Quant data shows VTVT's Minority Interest at -$357000.0 in Q2 2025, $977000.0 in Q1 2025, and $2.1 million in Q4 2024.